Saptalis Pharmaceuticals Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $404K

Saptalis Pharmaceuticals General Information

Description

Operator of a generic pharmaceutical company intended to develop non-sterile and sterile liquid and semi-solid dosage forms. The company develops, manufactures, and commercializes specialty generic prescription and over-the-counter products and has a pipeline of generic prescription and innovative pharmaceutical products utilizing ANDA and 505 (b)(2) regulatory pathways, providing customers with quality medicines at cost-effective prices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • 45 Davids Drive
  • Hauppauge, NY 11788
  • United States
+1 (631) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Saptalis Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - PPP 15-Apr-2020 $404K 00.00 Completed Startup
2. Seed Round 08-Nov-2016 00.00 00.00 Completed Startup
1. Seed Round 11-Sep-2015 $3M $3M Completed Startup
To view Saptalis Pharmaceuticals’s complete valuation and funding history, request access »

Saptalis Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Polireddy Dondeti Ph.D Founder, Chief Executive Officer, President & Chairman of the Board of Directors
Tatiana Akimova Ph.D Co-Founder, Executive Vice President of Corporate Development & Board Member
To view Saptalis Pharmaceuticals’s complete executive team members history, request access »

Saptalis Pharmaceuticals Board Members (2)

Name Representing Role Since
Polireddy Dondeti Ph.D Saptalis Pharmaceuticals Founder, Chief Executive Officer, President & Chairman of the Board of Directors 000 0000
Tatiana Akimova Ph.D Saptalis Pharmaceuticals Co-Founder, Executive Vice President of Corporate Development & Board Member 000 0000
To view Saptalis Pharmaceuticals’s complete board members history, request access »

Saptalis Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Saptalis Pharmaceuticals FAQs

  • When was Saptalis Pharmaceuticals founded?

    Saptalis Pharmaceuticals was founded in 2015.

  • Who is the founder of Saptalis Pharmaceuticals?

    Polireddy Dondeti Ph.D and Tatiana Akimova Ph.D are the founders of Saptalis Pharmaceuticals.

  • Who is the CEO of Saptalis Pharmaceuticals?

    Polireddy Dondeti Ph.D is the CEO of Saptalis Pharmaceuticals.

  • Where is Saptalis Pharmaceuticals headquartered?

    Saptalis Pharmaceuticals is headquartered in Hauppauge, NY.

  • What is the size of Saptalis Pharmaceuticals?

    Saptalis Pharmaceuticals has 40 total employees.

  • What industry is Saptalis Pharmaceuticals in?

    Saptalis Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Saptalis Pharmaceuticals a private or public company?

    Saptalis Pharmaceuticals is a Private company.

  • What is Saptalis Pharmaceuticals’s current revenue?

    The current revenue for Saptalis Pharmaceuticals is 000000.

  • How much funding has Saptalis Pharmaceuticals raised over time?

    Saptalis Pharmaceuticals has raised $9.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »